NCT02501109View on ClinicalTrials.gov

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Healthy volunteers will receive Aripiprazole Oral Soluble Fim(OSF) 10mg orally a single of dose within 28 days

Sponsors
All Listed Sponsors
lead

CMG Pharmaceutical Co. Ltd

INDUSTRY

NCT02501109 - Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers | Biotech Hunter | Biotech Hunter